Dabur, Maruti, Apollo Hospitals, Bajaj Finance stocks in focus with Union Budget initiating consumption-led economic recovery ...

Havells rallied as much as 6.53 per cent to hit an intraday high of Rs 1,669 per share, while Voltas zoomed 5.55 per cent to ...

Top brokerages shared their latest stock ratings. Macquarie maintains an Outperform on IndusInd Bank (Target: Rs 1,210) despite MFI challenges. CLSA retains Outperform on ONGC (Target: Rs 360) driven ...

Sun Pharma’s strong Q3 performance topped expectations, but concerns over Leqselvi’s delayed launch and reduced R&D spending have prompted caution amid brokerages.

The main drivers for Vedanta's positive outlook cited by analysts include strong performance in the aluminium, zinc, and oil ...

Following the Q3 earnings announcement, brokerages offered mixed views on the IndusInd Bank stock. Among the 50 analysts covering IndusInd Bank, 37 have a 'Buy' rating, 12 recommend 'Hold', while one ...

Samsung’s bottomline is feeling the effects of the US’ decision to limit China’s access to advanced AI technology. The company relies on its exports to China ...

According to Morgan Stanley, key things to watch are the extent of fiscal consolidation, physical and social infrastructure ...

Raymond James lifted their FY2024 earnings estimates for shares of Newmont in a research note issued on Monday, January 27th.

Sanjeev Rana, head of Korea research at CLSA, adds that Samsung Electronics' underperformance can be attributed to the ...

Brokerage firm Morgan Stanley has an "overweight" rating on the stock, with a price target of ₹4,278. It said that there is a ...

Brokerages remain bullish on key stocks. CLSA sees Tata Motors’ correction as a buying opportunity with strong JLR cash flows ...